日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Exogenous Thymosin Beta 4 Suppresses IPF-Lung Cancer in Mice: Possibly Associated with Its Inhibitory Effect on the JAK2/STAT3 Signaling Pathway

外源性胸腺肽β4抑制小鼠IPF-肺癌:可能与其对JAK2/STAT3信号通路的抑制作用有关

Rui Yu, Dandi Gao, Jiali Bao, Ronghao Sun, Mengqi Cui, Yunyun Mao, Kai Li, Enbo Hu, Yanfang Zhai, Yanhong Liu, Yuemei Gao, Ting Xiao, Honggang Zhou, Cheng Yang, Junjie Xu

Pan-cancer single-cell analysis reveals the heterogeneity and plasticity of cancer-associated fibroblasts in the tumor microenvironment

泛癌症单细胞分析揭示肿瘤微环境中癌症相关成纤维细胞的异质性和可塑性

Han Luo #, Xuyang Xia #, Li-Bin Huang #, Hyunsu An, Minyuan Cao, Gyeong Dae Kim, Hai-Ning Chen, Wei-Han Zhang, Yang Shu, Xiangyu Kong, Zhixiang Ren, Pei-Heng Li, Yang Liu, Huairong Tang, Ronghao Sun, Chao Li, Bing Bai, Weiguo Jia, Yi Liu, Wei Zhang, Li Yang, Yong Peng, Lunzhi Dai, Hongbo Hu, Yong Ji

circ_0000045 promotes proliferation, migration, and invasion of head and neck squamous cell carcinomas via regulating HSP70 and MAPK pathway

circ_0000045 通过调节 HSP70 和 MAPK 通路促进头颈部鳞状细胞癌的增殖、迁移和侵袭

Ronghao Sun, Yuqiu Zhou, Yongcong Cai, Chunyan Shui, Xu Wang, Jingqiang Zhu

Targeting androgen receptor (AR) with antiandrogen Enzalutamide increases prostate cancer cell invasion yet decreases bladder cancer cell invasion via differentially altering the AR/circRNA-ARC1/miR-125b-2-3p or miR-4736/PPARγ/MMP-9 signals

使用抗雄激素恩扎卢胺靶向雄激素受体 (AR) 可增加前列腺癌细胞的侵袭能力,但通过差异性地改变 AR/circRNA-ARC1/miR-125b-2-3p 或 miR-4736/PPARγ/MMP-9 信号通路,可降低膀胱癌细胞的侵袭能力。

Deng, Gang; Wang, Ronghao; Sun, Yin; Huang, Chi-Ping; Yeh, Shuyuan; You, Bosen; Feng, Changyong; Li, Gonghui; Ma, Shenglin; Chang, Chawnshang

Effect of dihydromyricetin on SARS-CoV-2 viral replication and pulmonary inflammation and fibrosis

二氢杨梅素对SARS-CoV-2病毒复制及肺部炎症和纤维化的影响

Ting Xiao, Yuli Wei, Mengqi Cui, Xiaohe Li, Hao Ruan, Liang Zhang, Jiali Bao, Shanfa Ren, Dandi Gao, Ming Wang, Ronghao Sun, Mingjiang Li, Jianping Lin, Dongmei Li, Cheng Yang, Honggang Zhou

Preclinical Study using Malat1 Small Interfering RNA or Androgen Receptor Splicing Variant 7 Degradation Enhancer ASC-J9(®) to Suppress Enzalutamide-resistant Prostate Cancer Progression

使用 Malat1 小干扰 RNA 或雄激素受体剪接变体 7 降解增强剂 ASC-J9(®) 抑制恩扎卢胺耐药性前列腺癌进展的临床前研究

Wang, Ronghao; Sun, Yin; Li, Lei; Niu, Yuanjie; Lin, Wanying; Lin, Changyi; Antonarakis, Emmanuel S; Luo, Jun; Yeh, Shuyuan; Chang, Chawnshang